WallStreetZenWallStreetZen

NASDAQ: HALO
Halozyme Therapeutics Inc Stock Ownership - Who owns Halozyme Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Halozyme Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Helen TorleyPRESIDENT AND CEO2025-06-2415,511$53.91
$836.21kSell
Helen TorleyPRESIDENT AND CEO2025-06-244,489$53.11
$238.41kSell
Helen TorleyPRESIDENT AND CEO2025-06-2420,000$8.11
$162.20kBuy
Helen TorleyPRESIDENT AND CEO2025-06-2320,000$8.11
$162.20kBuy
Helen TorleyPRESIDENT AND CEO2025-06-2320,000$52.57
$1.05MSell
Helen TorleyPRESIDENT AND CEO2025-06-2020,000$52.96
$1.06MSell
Helen TorleyPRESIDENT AND CEO2025-06-2020,000$8.11
$162.20kBuy
Mark Howard SnyderSVP CHIEF LEGAL OFFICER2025-06-122,711$54.54
$147.86kSell
Jeffrey William HendersonDirector2025-04-28200$61.00
$12.20kSell
Jeffrey William HendersonDirector2025-04-284,297$60.34
$259.27kSell

1 of 10

HALO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HALO insiders and whales buy or sell their stock.

HALO Shareholders

What type of owners hold Halozyme Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Randal J. Kirk21.61%26,633,924$1.44BInsider
Blackrock Inc13.87%17,092,111$926.73MInstitution
Vanguard Group Inc10.41%12,831,503$695.72MInstitution
State Street Corp4.91%6,053,007$328.19MInstitution
Invesco Ltd3.16%3,894,297$211.15MInstitution
Snyder Capital Management L P2.98%3,674,302$199.22MInstitution
Gregory Ian Frost2.96%3,641,380$197.44MInsider
Alliancebernstein LP2.61%3,215,109$174.32MInstitution
Geode Capital Management LLC2.57%3,169,240$171.84MInstitution
Macquarie Group Ltd2.17%2,674,273$145.00MInstitution

1 of 3

HALO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HALO77.82%22.18%Net SellingNet Selling
LEGN23.52%0.00%
RVMD90.58%9.42%Net BuyingNet Buying
JAZZ28.19%71.81%Net SellingNet Buying
IONS96.72%3.28%Net SellingNet Buying
View Top Biotech Stocks

Halozyme Therapeutics Stock Ownership FAQ

Who owns Halozyme Therapeutics?

Halozyme Therapeutics (NASDAQ: HALO) is owned by 98.61% institutional shareholders, 28.10% Halozyme Therapeutics insiders, and 0.00% retail investors. Randal J. Kirk is the largest individual Halozyme Therapeutics shareholder, owning 26.63M shares representing 21.61% of the company. Randal J. Kirk's Halozyme Therapeutics shares are currently valued at $1.49B.

If you're new to stock investing, here's how to buy Halozyme Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.